Venture Life Group (VLG) Competitors GBX 61.25 +1.25 (+2.08%) As of 08/1/2025 12:24 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock VLG vs. ANCR, EAH, DNL, STX, PXS, CHLL, MXC, RGT, CEL, and N4PShould you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Animalcare Group (ANCR), ECO Animal Health Group (EAH), Diurnal Group (DNL), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and N4 Pharma (N4P). These companies are all part of the "drug manufacturers - specialty & generic" industry. Venture Life Group vs. Its Competitors Animalcare Group ECO Animal Health Group Diurnal Group Shield Therapeutics Provexis Chill Brands Group Argent BioPharma Argent BioPharma Celadon Pharmaceuticals N4 Pharma Animalcare Group (LON:ANCR) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings. Which has more volatility and risk, ANCR or VLG? Animalcare Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, Venture Life Group has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Do insiders and institutionals have more ownership in ANCR or VLG? 49.0% of Animalcare Group shares are held by institutional investors. Comparatively, 69.5% of Venture Life Group shares are held by institutional investors. 29.5% of Animalcare Group shares are held by company insiders. Comparatively, 10.4% of Venture Life Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is ANCR or VLG more profitable? Animalcare Group has a net margin of 43.05% compared to Venture Life Group's net margin of 1.44%. Animalcare Group's return on equity of 36.62% beat Venture Life Group's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group43.05% 36.62% 2.97% Venture Life Group 1.44%0.99%1.56% Which has preferable valuation & earnings, ANCR or VLG? Animalcare Group has higher revenue and earnings than Venture Life Group. Animalcare Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£84.90M2.16£36.55M£53.645.00Venture Life Group£51.77M1.51£747.21K£0.59103.94 Does the media favor ANCR or VLG? In the previous week, Venture Life Group had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Venture Life Group and 0 mentions for Animalcare Group. Venture Life Group's average media sentiment score of 0.38 beat Animalcare Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the news media. Company Overall Sentiment Animalcare Group Neutral Venture Life Group Neutral SummaryAnimalcare Group beats Venture Life Group on 9 of the 13 factors compared between the two stocks. Get Venture Life Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLG vs. The Competition Export to ExcelMetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£78.05M£2.13B£5.53B£3.03BDividend Yield0.09%2.92%4.74%5.02%P/E Ratio103.944.2628.85176.75Price / Sales1.51677.32440.87264,362.45Price / Cash6.4010.3535.0727.97Price / Book1.0410.838.254.53Net Income£747.21K£21.15B£3.25B£5.90B7 Day Performance5.15%0.35%-3.73%12.58%1 Month Performance5.60%4.46%4.28%6.10%1 Year Performance26.29%2.65%25.84%71.60% Venture Life Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLGVenture Life GroupN/AGBX 61.25+2.1%N/A+28.9%£78.05M£51.77M103.94165News CoverageHigh Trading VolumeANCRAnimalcare GroupN/AGBX 270-0.7%N/A-2.6%£185.11M£84.90M5.03220EAHECO Animal Health Group3.5229 of 5 starsGBX 74.05-3.2%GBX 150+102.6%-27.6%£50.18M£89.44M47.87234DNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133STXShield TherapeuticsN/AGBX 4.53+0.6%N/A+46.1%£44.69M£20.92M-1.1740,000PXSProvexisN/AGBX 0.72-3.4%N/A+54.9%£16.90M£846.98K-27.304Gap DownCHLLChill Brands GroupN/AN/AN/AN/A£10.89M£624.19K-215.007MXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap UpRGTArgent BioPharmaN/AN/AN/AN/A£8.31MN/A-0.65N/AGap DownHigh Trading VolumeCELCeladon PharmaceuticalsN/AGBX 13.40flatN/AN/A£8.22M£123.38K-1.682,780N4PN4 PharmaN/AGBX 0.50+11.1%N/A-16.7%£2.15M£8.84K-1.445Gap Up Related Companies and Tools Related Companies Animalcare Group Competitors ECO Animal Health Group Competitors Diurnal Group Competitors Shield Therapeutics Competitors Provexis Competitors Chill Brands Group Competitors Argent BioPharma Competitors Argent BioPharma Competitors Celadon Pharmaceuticals Competitors N4 Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VLG) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venture Life Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Venture Life Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.